Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (51-60 of 342) with videos related to

Pageof 35
Sort By:
Human Reproduction Update|June 15, 2013
Antithrombotic therapy for pregnancy lossPaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
British Journal of Haematology|June 28, 2012
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long termPaulien G de Jong, Michiel Coppens, Saskia Middeldorp
Thrombosis Research|February 28, 2012
Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxisFederico Lussana, Michiel Coppens, Marco Cattaneo, et al.
The Cochrane Database of Systematic Reviews|August 6, 2014
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolismSaskia Middeldorp, Martin H Prins, Barbara A Hutten
Thrombosis and Haemostasis|June 4, 2020
Treatment of Venous Thromboembolism in Special Populations with Direct Oral AnticoagulantsRoisin Bavalia, Saskia Middeldorp, Gerhard Weisser, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromeStef Kaandorp, Marcello Di Nisio, Mariette Goddijn, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Thrombophilia testing for prevention of recurrent venous thromboembolismDanny Cohn, Fleur Vansenne, Corianne de Borgie, et al.
Seminars in Oncology|July 16, 2014
Effects of cancer on plateletsNick van Es, Auguste Sturk, Saskia Middeldorp, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
"Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": ReplyIngrid M Bistervels, Roisin Bavalia, Saskia Middeldorp, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Factor XI inhibitors: the holy grail of anticoagulant therapy?]Ralf E Harskamp, Saskia Middeldorp, Joris R De Groot
Pageof 35

Showing results (51-60 of 342) with videos related to

Sort By:
Pageof 35
Human Reproduction Update|June 15, 2013
Antithrombotic therapy for pregnancy lossPaulien G de Jong, Mariëtte Goddijn, Saskia Middeldorp
British Journal of Haematology|June 28, 2012
Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long termPaulien G de Jong, Michiel Coppens, Saskia Middeldorp
Thrombosis Research|February 28, 2012
Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxisFederico Lussana, Michiel Coppens, Marco Cattaneo, et al.
The Cochrane Database of Systematic Reviews|August 6, 2014
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolismSaskia Middeldorp, Martin H Prins, Barbara A Hutten
Thrombosis and Haemostasis|June 4, 2020
Treatment of Venous Thromboembolism in Special Populations with Direct Oral AnticoagulantsRoisin Bavalia, Saskia Middeldorp, Gerhard Weisser, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndromeStef Kaandorp, Marcello Di Nisio, Mariette Goddijn, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Thrombophilia testing for prevention of recurrent venous thromboembolismDanny Cohn, Fleur Vansenne, Corianne de Borgie, et al.
Seminars in Oncology|July 16, 2014
Effects of cancer on plateletsNick van Es, Auguste Sturk, Saskia Middeldorp, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2022
"Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": ReplyIngrid M Bistervels, Roisin Bavalia, Saskia Middeldorp, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Factor XI inhibitors: the holy grail of anticoagulant therapy?]Ralf E Harskamp, Saskia Middeldorp, Joris R De Groot
Pageof 35